HCPCS code J9046: Bortezomib injection, dr. Reddy's, per 0.1 mg2026 Medicare rate & RVUs in Texas
Reports Dr. Reddy's bortezomib product for oncology treatment, with each HCPCS unit representing 0.1 mg of drug administered.
CMS doesn’t publish an office rate for J9046 in Texas.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9046 covers
J9046 identifies Dr. Reddy's bortezomib injection, a proteasome inhibitor used in treatment regimens for multiple myeloma and mantle cell lymphoma. Oncology practices may administer bortezomib intravenously or subcutaneously. J9046 is a separate product-specific code, and the product is identified as not therapeutically equivalent to the bortezomib product represented by J9041; select the code that matches the product furnished.
CMS excludes J9046 from the physician fee schedule under status E. When Medicare covers the drug, it is treated as a Part B drug and generally priced using CMS's quarterly Average Sales Price drug files; coverage is left to the Medicare contractor's judgment. The code is reported by drug quantity: one unit represents 0.1 mg, so 1 mg corresponds to 10 units. Report the amount administered in units of 0.1 mg.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9046 pays more and less in Texas
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
8 of 8 payment localities
| Payment locality | Office | Facility |
|---|---|---|
| Austin, TX | Unavailable | Unavailable |
| Beaumont, TX | Unavailable | Unavailable |
| Brazoria, TX | Unavailable | Unavailable |
| Dallas, TX | Unavailable | Unavailable |
| Fort Worth, TX | Unavailable | Unavailable |
| Galveston, TX | Unavailable | Unavailable |
| Houston, TX | Unavailable | Unavailable |
| Rest of Texas | Unavailable | Unavailable |
How the J9046 rate is calculated
Each of J9046’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9046
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9046
J9046 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9046
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9046 isn’t priced in this setting.
J9046 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J9041Bortezomib injectionPer 0.1 mg
- J9041 represents a different bortezomib product. J9046 is specifically for Dr. Reddy's product and is designated as not therapeutically equivalent to J9041.
- J9048Bortezomib injectionFresenius Kabi, per 0.1 mg
- J9048 identifies a Fresenius Kabi bortezomib product; J9046 identifies Dr. Reddy's product. Choose according to the product administered.
- J9049Bortezomib injectionHospira product, per 0.1 mg
- J9049 identifies a Hospira bortezomib product, while J9046 identifies Dr. Reddy's product. These codes distinguish the products, not different drug quantities.
J9046 billing questions
How does J9046 differ from J9041?
J9046 identifies Dr. Reddy's bortezomib product, designated as not therapeutically equivalent to the product represented by J9041. Match the code to the specific product furnished.
How many units should be reported?
Each unit represents 0.1 mg. For example, 1 mg equals 10 units.
Which Medicare payment status applies?
CMS assigns status E, excluding J9046 from the physician fee schedule. When covered, it is a Part B drug generally priced through CMS's quarterly ASP drug files.
Does Medicare cover J9046?
Coverage is left to the Medicare contractor's judgment. The code's physician fee schedule status does not determine whether the drug is covered.
Which other bortezomib codes may be confused with J9046?
J9048, J9049, J9051, and J9054 identify other bortezomib products. Use the code matching the product administered rather than selecting among them by drug name alone.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9046 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist